Seminars in Nephrology
Volume 29, Issue 6 , Pages 587-593 , November 2009

Podocytes and Glomerular Function with Aging

  • Jocelyn Wiggins, BM, BCh, MRCP

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jocelyn E. Wiggins, BM, BCh, MRCP, Division of Geriatrics, Department of Internal Medicine, University of Michigan Health System, 1560 MSRBII, Box 5676, Ann Arbor, MI 48109-5676

References 

  1. U.S. Renal Data System. USRDS 2008 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;
  2. In:  Jennette JC,  Olson JL,  Schwartz MM,  Silva FG editor. Heptinstall's pathology of the kidney. 6th ed.. Philadelphia: Lippincott-Raven; 2006;
  3. Kaplan C, Pasternack B, Shah H, et al. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975;80:227–234
  4. Goyal VK. Changes with age in the human kidney. Exp Gerontol. 1982;17:321–331
  5. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–285
  6. Anderson S, Brenner BM. The aging kidney: structure, function, mechanisms and therapeutic implications. J Am Geriatr Soc. 1987;35:590–593
  7. Coleman GL, Barthold SW, Osbaldiston GW, Foster SJ, Jonas AM. Pathological changes during aging in barrier-reared Fischer 344 male rats. J Gerontol. 1977;32:258–278
  8. Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney. Exp Gerontol. 1986;21:379–406
  9. Brandis A, Bianchi G, Reale E, Helmchen U, Kuhn K. Age-dependant glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest. 1986;55:234–243
  10. Kleinknecht C, Laouari D, Hinglais N, Habib R, Dodu C, Lacour B, et al. Role of amount and nature of carbohydrates in the course of experimental renal failure. Kidney Int. 1986;30:687–693
  11. Tapp DC, Wortham WG, Addison JF, Hammonds DN, Barnes JL, Venkatachalam MA. Food restriction retards body growth and prevents end-stage renal pathology in remnant kidneys of rats regardless of protein intake. Lab Invest. 1989;60:184–195
  12. Keenan KP, Coleman JB, McCoy CL, Hoe CM, Soper KA, Laroque P. Chronic nephropathy in ad libitum overfed Sprague-Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth. Toxicol Pathol. 2000;28:788–798
  13. Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats (An autoradiographic analysis). Kidney Int. 1983;24:626–631
  14. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int. 1998;54:687–697
  15. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech. 2002;15:189–195
  16. Griffin SV, Petermann AT, Durvasula RV, Shankland SJ. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Nephrol Dial Transplant. 2003;18(Suppl 6):vi8–vi13
  17. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol. 2003;7:255–259
  18. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech. 2002;15:189–195
  19. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev. 2003;83:253–307
  20. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:575–582
  21. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000;24:349–354
  22. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000;24:251–256
  23. Laurens WE, Vanrenterghem YF, Steels PS, Van Damme BJ. A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat. Kidney Int. 1994;45:143–149
  24. Kretzler M, Koeppen-Hagemann I, Kritz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomized-desoxycorticosterone hypertensive rat. Virchows Arch. 1994;425:181–193
  25. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int. 2001;60:957–968
  26. Schiffer M, Bitzer M, Roberts IS, Kopp JB, Dijke P, Mundel P, et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001;108:807–816
  27. Wharram BL, Sanden SK, Filipiak WE, Goyal M, Wiggins JE, Saunders TL, et al. Podocyte depletion causes focal segmental glomerulosclerosis (FSGS) in rats. [abstract] J Am Soc Nephrol. 2004;15:240A
  28. Sharif K, Goyal M, Kershaw D, Kunkel R, Wiggins R. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS (A dedifferentiation hypothesis for the nephrotic syndrome). Exp Nephrol. 1998;6:234–244
  29. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10:51–61
  30. Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron. 2001;89:342–347
  31. Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M. Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract. 2003;95:c91–c99
  32. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003;285:F40–F48
  33. Floege J, Hackman B, Kliem V, Kriz W, Alpers CE, Johnson RJ, et al. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int. 1997;51:230–243
  34. Yu BP, Masoro EJ, McMahan CA. Nutritional influences on aging of Fischer 344 rats: I (Physical, metabolic, and longevity characteristics). J Gerontol. 1985;40:657–670
  35. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:461–464
  36. Mukhopadhyay A, Tissenbaum HA. Reproduction and longevity: secrets revealed by C. elegans. Trends Cell Biol. 2007;17:65–71
  37. Shaw P, Ocorr K, Bodmer R, Oldham S. Drosophila aging 2006/2007. Exp Gerontol. 2008;43:5–10
  38. Bartke A. New findings in transgenic, gene knockout and mutant mice. Exp Gerontol. 2006;41:1217–1219
  39. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol. 2008;173:327
  40. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, et al. Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16:2953–2966
  41. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, et al. APN Study Group: prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int. 2004;66:564–570
  42. Quaggin SE. Transcriptional regulation of podocyte specification and differentiation. Microsc Res Tech. 2002;57:208–211
  43. Patrakka J, Tryggvason K. Nephrin—a unique structural and signaling protein of the kidney filter. Trends Mol Med. 2007;13:396–403
  44. Thomas PE, Wharram BL, Goyal M, Wiggins JE, Holzman LB, Wiggins RC. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase (Identification, molecular cloning, and characterization in rabbit). J Biol Chem. 1994;269:19953–19962
  45. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol. 2004;15:2514–2527
  46. Wiggins JE, Goyal M, Wharram BL, Wiggins RC. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet. J Am Soc Nephrol. 2006;17:1382–1387
  47. Patel BN, Dunn RJ, Jeong SY, Julien J-P, David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002;22:6578–6586
  48. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann N Y Acad Sci. 1982;389:368–379
  49. Gutteridge JM. Iron and oxygen radicals in the brain. Ann Neurol. 1992;32:S16–S21
  50. Ferrucci L, Cavazzini C, Corsi A, Bartali B, Russo CR, Lauretani F, et al. Biomarkers of frailty in older persons. J Endocrinol Invest. 2002;25:S10–S15
  51. Cunningham J, Leffell M, Mearkle P, Harmatz P. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication. Metabolism. 1995;44:996–999

 Supported by grants from the National Institutes of Health (KO8 AG022019, DK46073, and P50 DK39255), and by pilot grant AG08808 from the Claude Pepper Older Americans Independence Center. Funding also was received from the Geriatric Research, Educational and Clinical Center from the Veterans Administration; technical assistance was received from Ronald Koenig, MD, Director of the Michigan National Institute of Diabetes and Digestive and Kidney Disease Biotechnology Center (DK58771).

PII: S0270-9295(09)00147-8

doi: 10.1016/j.semnephrol.2009.07.012

Seminars in Nephrology
Volume 29, Issue 6 , Pages 587-593 , November 2009

Article Tools

* Image Usage & Resolution